Close Menu

Scott Gottlieb, the former commissioner of the US Food and Drug Administration who resigned as head of the agency in April, has gone back to his old job: he has been rehired at the venture capital firm New Enterprise Associates (NEA) as a special partner on its healthcare investment team, according to MedCity News. Gottlieb had previously served as venture partner at NEA from 2007 until 2017, when he was appointed as FDA commissioner.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.